Cite
Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review
MLA
Carol L, Karp, et al. “Subconjunctival/Perilesional Recombinant Interferon Α2b for Ocular Surface Squamous Neoplasia: A 10-Year Review.” Ophthalmology, vol. 117, no. 12, Nov. 2009. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........5dac9f6538743ba1731c2d3295e63891&authtype=sso&custid=ns315887.
APA
Carol L, K., Anat, G., Sachin, C., Scott D, B., & Eduardo C, A. (2009). Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology, 117(12).
Chicago
Carol L, Karp, Galor Anat, Chhabra Sachin, Barnes Scott D, and Alfonso Eduardo C. 2009. “Subconjunctival/Perilesional Recombinant Interferon Α2b for Ocular Surface Squamous Neoplasia: A 10-Year Review.” Ophthalmology 117 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........5dac9f6538743ba1731c2d3295e63891&authtype=sso&custid=ns315887.